Contact Information
Phone: 414-266-2525
Fax: 414-266-2779
Email Me
Dr. Sander is involved in the clinical and research aspects of molecular pathology and laboratory medicine. As Scientific Director, Dr. Sander directs the development, operation, and expansion of the Molecular Diagnostics Laboratory at Children's Hospital of Wisconsin. This clinical laboratory provides state-of-the-art molecular testing for the diagnosis and treatment of children with non-infectious disease.
The clinical laboratory offers Pharmacogenetics testing for children evaluated in the Neurology Clinic as a way to better guide anticonvulsant medication therapy. In addition, the lab offers testing for Cystic Fibrosis and 22q11.2 deletion syndrome (i.e., DiGeorge Syndrome), which are used as aids in newborn screening and in confirmatory diagnostic testing. Goals of the laboratory include developing additional genetic tests for diseases and conditions including mitochondrial disorders, hearing loss, and vascular anomalies using cutting edge platforms such as next generation sequencing and droplet digital PCR. Dr. Sander also participates in translational research activities, bridging the areas of basic biology and clinical molecular diagnostics. Her aim is to work with investigators to identify genetic variations that cause congenital disorders and translate these discoveries to the clinic for the development of novel diagnostic tests for the pediatric population.